Dr. Stephen W. Behrman, MD

Dr. Behrman practices at Baptist Memorial Hospital-Memphis in Memphis, Tennessee, part of Baptist Memorial Health Care.

Dr. Behrman's NPI, 1942266713, was assigned on April 21, 2006. Dr. Behrman graduated from Boston University School Of Medicine in 1987. Dr. Behrman holds Tennessee license 29455.

Dr. Behrman's primary practice is Baptist Memorial Hospital-Memphis, at 6019 Walnut Grove Road, Memphis, TN 38120 in Shelby County. The practice phone is (901) 226-5000.

Dr. Behrman's primary practice is Baptist Memorial Hospital-Memphis in Memphis, Tennessee, part of Baptist Memorial Health Care. Dr. Behrman is also affiliated with Baptist Memorial Hospital-DeSoto. The medical group on file is Baptist Medical Group. Dmand AI also links Dr. Behrman to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Behrman practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Behrman's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Behrman is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Behrman's licenses on file in 4 states: Tennessee, California, Mississippi and Ohio.

Dmand AI lists abdominal adhesion surgery, abdominal hernia repair surgery, acute gallbladder or bile duct inflammation, colon removal, esophagus, stomach, or upper small intestine surgery and gallbladder removal among the conditions Dr. Behrman treats.

CMS data shows 209 Medicare services from Dr. Behrman across 9 procedure codes in 2024, for 119 Medicare patients. Medicare paid $18,729 for them.

CMS counts 119 Medicare patients who saw Dr. Behrman in 2024. The largest group is 65 to 74, with 70 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Behrman's median patient age at 72, with 46% women.

In 2024, Dr. Behrman wrote 18 Medicare Part D claims. 72% of them were for generic drugs. They cover 3 drugs, with $1,213 in total drug cost. In 2021, CMS named 87 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Behrman for performance year 2024, reported as part of a group. Dr. Behrman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 110 papers to Dr. Behrman, published from 2012 to 2025. 2018 was the busiest year, with 10. The most frequent topics are Pancreatic Neoplasms, Postoperative Complications and Pancreaticoduodenectomy. Dr. Behrman has published most often in HPB (Oxford). Dr. Behrman's most frequent co-authors are John David Christein, MD, Mark P. Callery, MD and Paxton V. Dickson, MD.

Dmand AI links Dr. Behrman to 3 clinical trials. 2 are still active or recruiting. Conditions studied include Carcinoma, Pancreatic Neoplasms and Pancreatic Diseases.

CMS Open Payments shows 29 general payments to Dr. Behrman from 16 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. W. L. Gore & Associates, Inc. paid the most, $229.

Dmand AI lists 4 awards for Dr. Behrman, most recently CMS Stage 1 EHR in 2014.

Dr. Behrman graduated from Boston University School Of Medicine in 1987. Dr. Behrman is a member of ACS.

Dr. Behrman is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.